GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
43.75
+0.15 (0.34%)
Feb 11, 2026, 1:30 PM CST
Market Cap1.81B -1.9%
Revenue (ttm)654.88M +19.3%
Net Income16.07M
EPS0.39
Shares Out41.46M
PE Ratio112.85
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,000
Average Volume23,859
Open43.60
Previous Close43.60
Day's Range43.60 - 43.75
52-Week Range39.20 - 67.10
Beta-0.23
RSI33.20
Earnings DateMar 13, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company offers microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well... [Read more]

Sector Healthcare
Founded 1999
Employees 144
Stock Exchange Taipei Exchange
Ticker Symbol 1796
Full Company Profile

Financial Performance

Financial Statements